ArticleOncogene2015

A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.

N Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.